ECKERT & ZIEGLER SE (EUZ.DE) Stock Fundamental Analysis

Europe • Frankfurt Stock Exchange • FRA:EUZ • DE0005659700

15.04 EUR
-0.02 (-0.13%)
Last: Feb 3, 2026, 10:27 AM
Fundamental Rating

7

Taking everything into account, EUZ scores 7 out of 10 in our fundamental rating. EUZ was compared to 68 industry peers in the Health Care Equipment & Supplies industry. EUZ has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. EUZ is not priced too expensively while it is growing strongly. Keep and eye on this one! With these ratings, EUZ could be worth investigating further for growth and quality investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • In the past year EUZ was profitable.
  • In the past year EUZ had a positive cash flow from operations.
  • EUZ had positive earnings in each of the past 5 years.
  • In the past 5 years EUZ always reported a positive cash flow from operatings.
EUZ.DE Yearly Net Income VS EBIT VS OCF VS FCFEUZ.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

1.2 Ratios

  • EUZ has a better Return On Assets (8.79%) than 85.29% of its industry peers.
  • With an excellent Return On Equity value of 17.17%, EUZ belongs to the best of the industry, outperforming 85.29% of the companies in the same industry.
  • EUZ has a Return On Invested Capital of 12.48%. This is amongst the best in the industry. EUZ outperforms 86.76% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for EUZ is in line with the industry average of 9.62%.
  • The 3 year average ROIC (9.92%) for EUZ is below the current ROIC(12.48%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.79%
ROE 17.17%
ROIC 12.48%
ROA(3y)6.9%
ROA(5y)7.6%
ROE(3y)13.51%
ROE(5y)14.72%
ROIC(3y)9.92%
ROIC(5y)9.15%
EUZ.DE Yearly ROA, ROE, ROICEUZ.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

  • EUZ has a better Profit Margin (13.06%) than 77.94% of its industry peers.
  • In the last couple of years the Profit Margin of EUZ has declined.
  • The Operating Margin of EUZ (21.27%) is better than 86.76% of its industry peers.
  • EUZ's Operating Margin has improved in the last couple of years.
  • EUZ has a worse Gross Margin (47.25%) than 64.71% of its industry peers.
  • In the last couple of years the Gross Margin of EUZ has remained more or less at the same level.
Industry RankSector Rank
OM 21.27%
PM (TTM) 13.06%
GM 47.25%
OM growth 3Y9.05%
OM growth 5Y5.71%
PM growth 3Y-16.23%
PM growth 5Y-1.83%
GM growth 3Y-1.4%
GM growth 5Y-0.15%
EUZ.DE Yearly Profit, Operating, Gross MarginsEUZ.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

8

2. Health

2.1 Basic Checks

  • EUZ has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • EUZ has about the same amout of shares outstanding than it did 1 year ago.
  • EUZ has more shares outstanding than it did 5 years ago.
  • EUZ has a better debt/assets ratio than last year.
EUZ.DE Yearly Shares OutstandingEUZ.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
EUZ.DE Yearly Total Debt VS Total AssetsEUZ.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • EUZ has an Altman-Z score of 4.63. This indicates that EUZ is financially healthy and has little risk of bankruptcy at the moment.
  • With a decent Altman-Z score value of 4.63, EUZ is doing good in the industry, outperforming 79.41% of the companies in the same industry.
  • EUZ has a debt to FCF ratio of 1.05. This is a very positive value and a sign of high solvency as it would only need 1.05 years to pay back of all of its debts.
  • EUZ has a better Debt to FCF ratio (1.05) than 88.24% of its industry peers.
  • A Debt/Equity ratio of 0.16 indicates that EUZ is not too dependend on debt financing.
  • The Debt to Equity ratio of EUZ (0.16) is better than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 1.05
Altman-Z 4.63
ROIC/WACC1.75
WACC7.12%
EUZ.DE Yearly LT Debt VS Equity VS FCFEUZ.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

  • A Current Ratio of 2.93 indicates that EUZ has no problem at all paying its short term obligations.
  • EUZ has a Current ratio of 2.93. This is amongst the best in the industry. EUZ outperforms 80.88% of its industry peers.
  • A Quick Ratio of 2.37 indicates that EUZ has no problem at all paying its short term obligations.
  • Looking at the Quick ratio, with a value of 2.37, EUZ belongs to the top of the industry, outperforming 88.24% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.93
Quick Ratio 2.37
EUZ.DE Yearly Current Assets VS Current LiabilitesEUZ.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

7

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 43.67% over the past year.
  • The Earnings Per Share has been growing by 8.65% on average over the past years. This is quite good.
  • The Revenue has grown by 9.64% in the past year. This is quite good.
  • Measured over the past years, EUZ shows a quite strong growth in Revenue. The Revenue has been growing by 10.63% on average per year.
EPS 1Y (TTM)43.67%
EPS 3Y-1.23%
EPS 5Y8.65%
EPS Q2Q%68.5%
Revenue 1Y (TTM)9.64%
Revenue growth 3Y17.92%
Revenue growth 5Y10.63%
Sales Q2Q%7.42%

3.2 Future

  • EUZ is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.41% yearly.
  • Based on estimates for the next years, EUZ will show a quite strong growth in Revenue. The Revenue will grow by 8.09% on average per year.
EPS Next Y52.31%
EPS Next 2Y16.15%
EPS Next 3Y16.41%
EPS Next 5YN/A
Revenue Next Year8.58%
Revenue Next 2Y7.81%
Revenue Next 3Y8.09%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
EUZ.DE Yearly Revenue VS EstimatesEUZ.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
EUZ.DE Yearly EPS VS EstimatesEUZ.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8

5

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 23.14, the valuation of EUZ can be described as rather expensive.
  • Based on the Price/Earnings ratio, EUZ is valued a bit cheaper than the industry average as 64.71% of the companies are valued more expensively.
  • The average S&P500 Price/Earnings ratio is at 28.41. EUZ is around the same levels.
  • With a Price/Forward Earnings ratio of 18.00, EUZ is valued on the expensive side.
  • Based on the Price/Forward Earnings ratio, EUZ is valued a bit cheaper than the industry average as 61.76% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 25.64, EUZ is valued a bit cheaper.
Industry RankSector Rank
PE 23.14
Fwd PE 18
EUZ.DE Price Earnings VS Forward Price EarningsEUZ.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 77.94% of the companies in the same industry are more expensive than EUZ, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, EUZ is valued a bit cheaper than 72.06% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.58
EV/EBITDA 10.3
EUZ.DE Per share dataEUZ.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

  • EUZ's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of EUZ may justify a higher PE ratio.
  • A more expensive valuation may be justified as EUZ's earnings are expected to grow with 16.41% in the coming years.
PEG (NY)0.44
PEG (5Y)2.67
EPS Next 2Y16.15%
EPS Next 3Y16.41%

3

5. Dividend

5.1 Amount

  • EUZ has a Yearly Dividend Yield of 1.10%. Purely for dividend investing, there may be better candidates out there.
  • EUZ's Dividend Yield is a higher than the industry average which is at 1.03.
  • Compared to the average S&P500 Dividend Yield of 1.83, EUZ is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.1%

5.2 History

  • The dividend of EUZ decreases each year by -43.97%.
Dividend Growth(5Y)-43.97%
Div Incr Years1
Div Non Decr Years3
EUZ.DE Yearly Dividends per shareEUZ.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • EUZ pays out 26.23% of its income as dividend. This is a sustainable payout ratio.
DP26.23%
EPS Next 2Y16.15%
EPS Next 3Y16.41%
EUZ.DE Yearly Income VS Free CF VS DividendEUZ.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
EUZ.DE Dividend Payout.EUZ.DE Dividend Payout, showing the Payout Ratio.EUZ.DE Dividend Payout.PayoutRetained Earnings

ECKERT & ZIEGLER SE

FRA:EUZ (2/3/2026, 10:27:02 AM)

15.04

-0.02 (-0.13%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-13
Earnings (Next)03-26
Inst Owners30.9%
Inst Owner ChangeN/A
Ins Owners0.23%
Ins Owner ChangeN/A
Market Cap955.34M
Revenue(TTM)304.47M
Net Income(TTM)39.75M
Analysts80
Price Target22.06 (46.68%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.1%
Yearly Dividend0.02
Dividend Growth(5Y)-43.97%
DP26.23%
Div Incr Years1
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.53%
PT rev (3m)-3.75%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.23%
EPS NY rev (3m)17.1%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.16%
Valuation
Industry RankSector Rank
PE 23.14
Fwd PE 18
P/S 3.14
P/FCF 21.58
P/OCF 14.37
P/B 4.13
P/tB 5.13
EV/EBITDA 10.3
EPS(TTM)0.65
EY4.32%
EPS(NY)0.84
Fwd EY5.56%
FCF(TTM)0.7
FCFY4.63%
OCF(TTM)1.05
OCFY6.96%
SpS4.79
BVpS3.65
TBVpS2.93
PEG (NY)0.44
PEG (5Y)2.67
Graham Number7.3
Profitability
Industry RankSector Rank
ROA 8.79%
ROE 17.17%
ROCE 17.57%
ROIC 12.48%
ROICexc 18.59%
ROICexgc 22.77%
OM 21.27%
PM (TTM) 13.06%
GM 47.25%
FCFM 14.54%
ROA(3y)6.9%
ROA(5y)7.6%
ROE(3y)13.51%
ROE(5y)14.72%
ROIC(3y)9.92%
ROIC(5y)9.15%
ROICexc(3y)13.44%
ROICexc(5y)13%
ROICexgc(3y)17.78%
ROICexgc(5y)17.59%
ROCE(3y)13.96%
ROCE(5y)12.89%
ROICexgc growth 3Y11.22%
ROICexgc growth 5Y1.55%
ROICexc growth 3Y17.53%
ROICexc growth 5Y5.68%
OM growth 3Y9.05%
OM growth 5Y5.71%
PM growth 3Y-16.23%
PM growth 5Y-1.83%
GM growth 3Y-1.4%
GM growth 5Y-0.15%
F-Score7
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 1.05
Debt/EBITDA 0.43
Cap/Depr 106.5%
Cap/Sales 7.3%
Interest Coverage 85.33
Cash Conversion 77.65%
Profit Quality 111.36%
Current Ratio 2.93
Quick Ratio 2.37
Altman-Z 4.63
F-Score7
WACC7.12%
ROIC/WACC1.75
Cap/Depr(3y)190.39%
Cap/Depr(5y)187.58%
Cap/Sales(3y)10.17%
Cap/Sales(5y)10.1%
Profit Quality(3y)67.54%
Profit Quality(5y)69.62%
High Growth Momentum
Growth
EPS 1Y (TTM)43.67%
EPS 3Y-1.23%
EPS 5Y8.65%
EPS Q2Q%68.5%
EPS Next Y52.31%
EPS Next 2Y16.15%
EPS Next 3Y16.41%
EPS Next 5YN/A
Revenue 1Y (TTM)9.64%
Revenue growth 3Y17.92%
Revenue growth 5Y10.63%
Sales Q2Q%7.42%
Revenue Next Year8.58%
Revenue Next 2Y7.81%
Revenue Next 3Y8.09%
Revenue Next 5YN/A
EBIT growth 1Y7.47%
EBIT growth 3Y28.59%
EBIT growth 5Y16.95%
EBIT Next Year46.97%
EBIT Next 3Y20.11%
EBIT Next 5YN/A
FCF growth 1Y300.82%
FCF growth 3Y114.55%
FCF growth 5Y8.28%
OCF growth 1Y52.85%
OCF growth 3Y25.28%
OCF growth 5Y10.49%

ECKERT & ZIEGLER SE / EUZ.DE FAQ

What is the fundamental rating for EUZ stock?

ChartMill assigns a fundamental rating of 7 / 10 to EUZ.DE.


Can you provide the valuation status for ECKERT & ZIEGLER SE?

ChartMill assigns a valuation rating of 5 / 10 to ECKERT & ZIEGLER SE (EUZ.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for ECKERT & ZIEGLER SE?

ECKERT & ZIEGLER SE (EUZ.DE) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for EUZ stock?

The Price/Earnings (PE) ratio for ECKERT & ZIEGLER SE (EUZ.DE) is 23.14 and the Price/Book (PB) ratio is 4.13.


Can you provide the dividend sustainability for EUZ stock?

The dividend rating of ECKERT & ZIEGLER SE (EUZ.DE) is 3 / 10 and the dividend payout ratio is 26.23%.